Suraksha Diagnostic gets Sebi's go ahead to raise funds through IPO

Q: How long will it take to read this news story?

The story "Suraksha Diagnostic gets Sebi&#039;s go ahead to raise funds through IPO" has 424 words across 15 sentences, which will take approximately 2 - 4 minutes for the average person to read.

Q: Which news outlet covered this story?

The story "Suraksha Diagnostic gets Sebi&#039;s go ahead to raise funds through IPO" was covered 5 hours ago by Business Standard, a news publisher based in India.

Q: How trustworthy is 'Business Standard' news outlet?

Business Standard is a fully independent (privately-owned) news outlet established in 1975 that covers mostly business and finance news. The outlet is headquartered in India and publishes an average of 314 news stories per day. It's most recent story was published 2 hours ago.

Q: What do people currently think of this news story?

The sentiment for this story is currently Neutral, indicating that people are not responding positively or negatively to this news.

Q: How do I report this news for inaccuracy?

You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.<ul><li>News ID: #22922990</li><li>URL: https://beamstart.com/news/suraksha-diagnostic-gets-sebis-go-17283039643770</li></ul>

Business Standard Logo Business Standard 5h ago

Suraksha Diagnostic gets Sebi's go ahead to raise funds through IPO - Business Standard

Quick Summary:

Integrated diagnostic chain Suraksha Diagnostic Ltd has received Sebi's go ahead to raise funds through an initial public offering (IPO), an update with the markets regulator showed on Monday.

The Kolkata-headquartered company's proposed IPO consists of an Offer-for-Sale (OFS) of up to 1.92 crore equity shares by promoters and investor shareholders, with no fresh issue component, according to the Draft Red Herring Prospectus (DRHP).

Under the OFS, promoters -- Somnath Chatterjee, Ritu Mittal, Satish Kumar Verma and investors -- OrbiMed Asia II Mauritius Ltd, Munna Lal Kejriwal and Santosh Kumar Kejriwal will offload shares.